The Pacific Coast has dominated breast augmentation for two decades — performing 37% of all procedures with just 16% of the population. But COVID reshuffled the regional map, and the South Atlantic is surging.
With just 16% of the US population, the Pacific region (CA, OR, WA, AK, HI) consistently performs 34–38% of all breast augmentations. From 2006 through 2024 — 18 years — the Pacific never dropped below 34% or exceeded 38%. California's combination of Hollywood culture, surgeon density, and year-round warm weather creates permanently high baseline demand.
The most useful way to assess regional augmentation is the ratio of procedure share to population share. The Pacific performs at 2.3x its population weight — far and away the most augmentation-dense region. The South Atlantic just reached parity. Every other region underperforms.
The most significant regional shift in the dataset is the South Atlantic's post-COVID jump. After holding at 15–17% for the entire 2007–2018 period, Region 3 surged to 21% in 2022 and has held at 20–21% since. That's a 24% increase in procedure count while the national total barely grew.
What's driving it: Florida gained 2M+ residents from 2018–2024, no state income tax boosts discretionary spending, Miami built massive cosmetic surgery tourism infrastructure, and Charlotte/Atlanta emerged as new surgical hubs.
The Northeast's share dropped from a stable 15% (2007–2018) to 11% (2022–2024) — a loss of roughly 12,000 annual procedures. Population outmigration, cost-of-living squeeze, cultural shift toward "natural beauty," and surgeon retirement without replacement all contribute.
The regional map was remarkably stable from 2007–2018 — then COVID compressed years of migration-driven change into 24 months. The breast augmentation regional data mirrors the broader American story: the Sun Belt is winning, the Northeast is shrinking, and the West Coast operates by its own rules.